Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Third party research

Generic: Sales growth re-established above 10% - ABG

Generic Sweden

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Finding a new level of growth post COVID-19
Impressive profitability in Q4
Low churn confirmed, as expected


Q4: Sales growth of 12% and an EBIT margin of 21.5%

Generic reported solid Q4 results with net sales of SEK 34.2m (+12% y-o-y). Growth picked up a bit more compared to Q3 (+11% y-o-y) as the company is finding a new plateau after the deal with The Swedish Social Insurance Office and COVID-19 boosted 2021. Sales were in line with ABGSCe but profitability clearly higher. EBIT was SEK 7.4m (5.1m) for a margin of 21.5% (16.8%). EBIT was 25% above ABGSCe, partly thanks to a higher gross margin but mainly due to lower personnel costs. The board proposed a dividend SEK 1.25 (1.00) per share.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.